WHO Given 90% Documents For Covaxin's Emergency Listing: Bharat Biotech

The remaining documents are expected to be submitted by June, the Hyderabad-based Bharat Biotech Ltd told the Central government.

Bharat Biotech International Limited (BBIL) has conveyed to the government that it has already submitted 90 per cent of documents to WHO for obtaining emergency use listing (EUL) for the Covaxin vaccine, sources said on Monday. The remaining documents are expected to be submitted by June, the Hyderabad-based Bharat Biotech Ltd told the Central government during a discussion on obtaining the World Health Organisation's authorisation for emergency use listing for Covaxin, sources said. "BBIL is confident about obtaining WHO's emergency use listing," said a source. Sources also said that no country has instituted a ''vaccine passport'' and that countries around the world have their own requirements for approval which, in most cases, involves travel by carrying a COVID-19 negative RT-PCR report.